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Background. Neurocognitive deﬁcits are important aspects of the schizophrenic disorders because they have a strong
impact on social and vocational outcomes. We expanded on previous research by focusing on the neurocognitive proﬁles
of persons at high risk (HR) or ultra-high risk (UHR) for schizophrenic and affective psychoses. Our main aim was to
determine whether neurocognitive measures are sufﬁciently sensitive to predict a group afﬁliation based on deﬁcits in
functional domains.
Method. This study included 207 help-seeking individuals identiﬁed as HR (n=75), UHR (n=102) or at high risk for
bipolar disorder (HRBip; n=30), who were compared with persons comprising a matched, healthy control group (CG;
n=50). Neuropsychological variables were sorted according to their load in a factor analysis and were compared
among groups. In addition, the likelihood of group membership was estimated using logistic regression analyses.
Results. The performance of HR and HRBip participants was comparable, and intermediate between the controls and
UHR. The domain of processing speed was most sensitive in discriminating HR and UHR [odds ratio (OR) 0.48, 95%
conﬁdence interval (CI) 0.28–0.78, p=0.004] whereas learning and memory deﬁcits predicted a conversion to schizo-
phrenic psychosis (OR 0.47, 95% CI 0.25–0.87, p=0.01).
Conclusions. Performances on neurocognitive tests differed among our three at-risk groups and may therefore be useful
in predicting psychosis. Overall, cognition had a profound effect on the extent of general functioning and satisfaction
with life for subjects at risk of psychosis. Thus, this factor should become a treatment target in itself.
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Introduction
Neurocognitive deﬁcits are an important aspect of the
schizophrenic disorders. They may determine social
and vocational outcomes even more than psycho-
pathological symptoms. Environmental factors and
social adjustment, such as the level of isolation or abil-
ity to function outside the nuclear family, are predic-
tors of a ﬁrst psychosis in subjects at ultra-high risk
(Dragt et al. 2011). Because the capacity to process
socially relevant information also relies on basic neuro-
cognitive abilities (i.e. attention and memory), deﬁcits
in these domains may strongly inﬂuence the social
embedment and ability to cope with early psychotic
symptoms (Green et al. 2000). According to the neuro-
developmental hypothesis of pathogenesis in schizo-
phrenia, along with recent ﬁndings, neurocognitive
deﬁcits are most likely to be present prior to the mani-
festation of full-blown schizophrenia (Giuliano et al.
2012). This supposition is also supported by a recent
large population study of young Swiss conscripts by
Müller et al. (2013), who found signiﬁcantly frequent
evidence of cognitive impairments early in life for indi-
viduals who were later diagnosed with schizophrenia.
Therefore, an assessment of cognitive functioning
should be taken into account in early detection of psy-
choses. Because impairments can be quantiﬁed before
the onset of the illness, researchers have proposed
using them as an additional indicator when optimizing
the prediction of psychosis risk (Riecher-Rössler et al.
2009, 2013). Moreover, to create useful interventions
in the pre-psychotic phase, it is essential that we
* Address for correspondence: S. Metzler, Ph.D., The Zurich
Program for Sustainable Development of Mental Health Services
(ZInEP), University Hospital of Psychiatry Zurich, Militärstrasse 8,
Postfach 1930, Zurich 8021, Switzerland.
(Email: sibylle.metzler@dgsp.uzh.ch)
Psychological Medicine (2014), 44, 3543–3555. © Cambridge University Press 2014
doi:10.1017/S0033291714001007
ORIGINAL ARTICLE
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291714001007
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 17:01:27, subject to the Cambridge Core terms of use, available at
learn more about deﬁcits during this early stage of ill-
ness so that we can identify individuals truly in need
of help and provide appropriate intervention.
This study applied the ultra-high-risk (UHR) criteria
conceptualized by Yung & McGorry (1996), which in-
dicate an imminent transition to schizophrenia. These
criteria include the manifestation of attenuated positive
symptoms (APS), brief intermittent psychotic symp-
toms (BLIPS) or a state–trait component that combines
vulnerability with a distinct reduction in global
functioning within the past year. The literature shows
that transition rates in UHR groups vary by 30% to
35% within 1 to 3 years (Cornblatt et al. 2003; Yung
et al. 2003; Cannon et al. 2008). According to previous
theoretical considerations (Klosterkotter et al. 2011;
Keshavan et al. 2011; Fusar-Poli et al. 2013), a putative
earlier at-risk state may involve the basic symptom con-
cept of Huber (1966). In this approach, deﬁned here as
a high-risk (HR) criterion, help-seeking individuals
mainly describe the disturbing experience of subtle
and self-reported alterations and deﬁcits observed in
cognition, thoughts and perception (Klosterkotter et al.
2001). In the Cologne Early Recognition Study, the con-
version rates to schizophrenia in individuals presenting
cognitive–perceptual basic symptoms at baseline were
reported to be less than 1% in 1 year but rose to 48%
after 4 years (Klosterkotter et al. 2001; Schultze-Lutter
et al. 2010).
The prospective identiﬁcation of subjects at high
risk of psychosis has received increasing interest from
researchers (Fusar-Poli et al. 2013). However, it is also
debated because individuals putatively suffering
from prodromal symptoms may have outcomes other
than psychosis (Ruhrmann et al. 2010; Yung et al.
2010; Fusar-Poli et al. 2014). Moreover, the overlap
and differences among various criteria have been criti-
cized (Schultze-Lutter et al. 2011). Nevertheless, indivi-
duals meeting at-risk criteria obviously have cognitive
and functional deﬁcits for which they seek help and
are in need of the appropriate treatment (Ruhrmann
et al. 2010). Furthermore, studying the manifestation
of symptoms in a putative at-risk state of psychosis is
warranted because the confounding effects of ongoing
illness, treatment and other complications may then
possibly be avoided.
The continuum model of psychosis underlying these
at-risk studies emphasizes the many similarities across
different psychotic diagnostic categories. However,
these disorders also have important differences. This
is especially true for affective psychoses (depression
with psychotic features or bipolar disorder with psy-
chotic features) versus schizophrenic psychoses (schizo-
phrenia, schizophreniform disorder or schizo-affective
disorder). Efforts to create diagnostic tools for early
detection of bipolar disorder are essential because,
currently, correct diagnoses are often delayed by 8 to
10 years (Angst et al. 2005). However, the development
of at-risk criteria for bipolar disorder is still in an early
stage. Based on ﬁndings from prospective studies, the
presence of hypomanic symptoms in adolescence is
strongly predictive of later bipolar disorders. As
such, it has been hypothesized that applying an instru-
ment for self-assessment of hypomanic symptoms
might increase the detection of bipolar disorders
(Angst et al. 2005). Therefore, help-seeking individuals
with prominent depressive and/or hypomanic symp-
toms, but who do not meet the HR or UHR criteria,
have been classiﬁed as high-risk bipolar (HRBip).
Recent meta-analyses of the at-risk state for schizo-
phrenic psychosis have conﬁrmed that impairments
in neuropsychological performance (Fusar-Poli et al.
2012b; Giuliano et al. 2012), along with alterations in
brain structure (Mechelli et al. 2011; Fusar-Poli,
2012b), social cognition (Fusar-Poli et al. 2010) and
general functioning and neurochemistry (Smieskova
et al. 2013), are associated with a clinically high risk
(Addington & Heinssen, 2012; Fusar-Poli et al. 2013).
Studies of cognition in such individuals have found
small to medium impairments across most neurocogni-
tive domains that are at an intermediate level between
those of healthy individuals and subjects diagnosed
with schizophrenia (Hawkins et al. 2004; Brewer
et al. 2006; Pukrop et al. 2006; Eastvold et al. 2007;
Fusar-Poli et al. 2012b). Moreover, individuals at risk
who later convert to psychosis show more severe base-
line neurocognitive deﬁcits in almost all domains when
compared with non-converters, especially for proces-
sing speed, verbal ﬂuency and memory (Pukrop &
Klosterkotter, 2010; Giuliano et al. 2012). To our knowl-
edge, only a few studies have directly compared
putative HR (deﬁned by basic symptoms) and UHR
psychosis groups. For example, Frommann et al.
(2011) identiﬁed an executive control impairment in
the early (HR) state but additional memory dysfunc-
tion in the late (UHR) prodromal state. Simon et al.
(2007) reported equivalent neurocognitive perfor-
mances in subjects meeting basic symptom or UHR
criteria.
Research on clinical and neurobiological markers
in help-seeking individuals at risk for progression to
bipolar disorder is still limited and inconsistent
(Bechdolf et al. 2012). An earlier prospective birth
cohort study found early in the developmental course
of the disorder impairments in tasks that involve psy-
chomotor speed and also attentional and executive
abilities (Cannon et al. 2006). However, this was true
only for subjects who later developed a schizophrenic
disorder and not for individuals who subsequently
developed an affective disorder. Therefore, the authors
concluded that early motor and attentional or
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executive impairments may be speciﬁc to schizo-
phrenia-related rather than affective disorder out-
comes. Ratheesh et al. (2013) reported lower global
functioning in at-risk subjects who converted to bipolar
disorder than in thosewhodid not, although differences
in neurocognitive characteristics could not be detected.
Conversely, a literature review by Olvet et al. (2013)
suggested that deﬁcits in speciﬁc neurocognitive
domains, such as verbal memory and executive func-
tion, represented potential predictors of bipolar dis-
orders. Therefore, investigating the nature of deﬁcits
and symptoms in individuals with an increased risk
of developing an affective or schizophrenic disorder
might provide further insight into the neuropatho-
physiological mechanisms underlying both illnesses.
Our study objectives were to explore the neuro-
cognitive functioning in an at-risk population and to
determine whether neurocognitive measures are sensi-
tive enough to differentiate among HR, UHR and
HRBip individuals. This examination expanded upon
previous research by addressing the neurocognitive
functions and clinical characteristics of persons at
high and ultra-high risk of schizophrenic psychosis,
subjects at risk for bipolar disorder, and a group of
matched, healthy controls. Accordingly, we hypothe-
sized that (1) HR and UHR subjects exhibit generalized
neurocognitive deﬁcits compared with the control
group, (2) deﬁcits in measures of learning and memory
are associated with more severe psychopathological
symptoms, and (3) persons within the HRBip group
have fewer deﬁcits in their psychomotor speed-
dependent tasks than do those in either the HR or
the UHR group.
Method
Subjects
Individuals were recruited within the context of a study
on early recognition of psychosis, the Zurich Program
for Sustainable Development of Mental Health
Services (ZInEP, Zürcher Impulsprogramm zur nach-
haltigen Entwicklung der Psychiatrie; www.zinep.ch)
from the canton of Zurich, Switzerland. Potential
participants had either learned about this study from
a project website, ﬂyers or newspaper advertisements,
or were referred to our staff by general practitioners,
school psychologists, counselling services, psychiatrists
or psychologists. All subjects spoke standard German
and had normal or corrected-to-normal vision, normal
hearing, and normal motor limb function. Those aged
518 years provided informed consent whereas minors
(<18 years) gave assent in conjunction with parental
informed consent. The study was approved by the
Ethics Committee of the canton Zurich and was carried
out in accordance with the Declaration of Helsinki.
The ZInEP project included 221 subjects in total.
Complete neuropsychological data were available
from 207 participants who fulﬁlled the criteria (see
psychopathological assessment below) for either HR
(n=75), UHR (n=102) or HRBip (n=30). For compari-
son, 50 healthy persons, comprising our control
group (CG), were recruited by advertisements in the
local newspaper or by word of mouth. Their
qualifying data had suggested they were comparable
in verbal intelligence, level of education and gender
to persons in the other groups. Exclusion criteria
for study participation were manifest schizophrenic,
substance-induced or organic psychosis; current
substance or alcohol dependence; or an estimated
verbal IQ<80. Controls were screened with the Mini
International Neuropsychiatric Interview (MINI;
Sheehan et al. 1998) based on DSM-IV criteria to
exclude persons with any past or present psychiatric,
neurological or somatic disorder that might bias their
cognition. None of the controls were using psycho-
tropic medication or illicit drugs. Demographic and
clinical data for the study groups are displayed
in Table 1.
Psychopathological assessment
To qualify for inclusion, participants had to fulﬁll at
least one of the following requirements.
(1) HR: high-risk status for psychosis, as assessed
by the Schizophrenia Proneness Instrument,
SPI-A (Adult Version) or SPI-CY (Child and
Youth Version) (Schultze-Lutter et al. 2007;
Schultze-Lutter & Koch, 2009), having at least one
cognitive–perceptual basic symptom or at least
two cognitive disturbances, and not meeting any
of the UHR inclusion criteria listed below.
(2) UHR: ultra-high-risk status for psychosis, as
rated by the Structured Interview for Prodromal
Syndromes (SIPS; Miller et al. 2003), having at
least one attenuated psychotic symptom or at
least one brief limited intermittent psychotic symp-
tom, or meeting the state–trait criterion of a re-
duction in Global Assessment of Functioning
(GAF; Endicott et al. 1976) score of>30% in
the past year, plus either a schizotypal personality
disorder or a ﬁrst-degree relative with psychosis.
(3) HRBip: high risk for bipolar disorder, as deﬁned
by a score of either 514 on the Hypomania
Checklist (HCL; Angst et al. 2005), a self-report
measure of lifetime hypomanic symptoms, or a
score of 512 on the Hamilton Depression Rating
Scale (HAMD; Schutte & Malouff, 1995), and not
meeting any of the at-risk psychosis inclusion cri-
teria listed above.
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A transition to schizophrenia and bipolar disorder
was diagnosed according to ICD-10. Quantitative
measures of psychopathology were further obtained
as follows: psychotic symptoms using the Positive
and Negative Syndrome Scale (PANSS; Kay et al.
1987), current Axis-I co-morbidity using the MINI
(Sheehan et al. 1998), general functioning according to
the GAF (Endicott et al. 1976), and satisfaction with
psychosocial domains of life using the Manchester
Short Assessment of Quality of Life (MANSA; Priebe
et al. 1999). This assessment was conducted by trained,
experienced psychiatrists or psychologists.
Neurocognitive assessment
A set of well-established neuropsychological tests was
administered in a ﬁxed order. Testing and scoring were
performed blind to diagnostic status. The tests were
chosen on the basis of their demonstrated reliability
and capacity to discriminate clinically high-risk sub-
jects from healthy controls. Verbal IQ was estimated
with a German word recognition test, the Multiple
Choice Vocabulary Intelligence Test (Mehrfachwahl-
Wortschatz-Intelligenztest, MWT-B; Lehrl, 1989), for
adults or a test of receptive vocabulary for minors,
the Peabody Picture Vocabulary Test (PPVT; Dunn &
Dunn, 2003). For the purposes of data reduction and
examining generalized and speciﬁc deﬁcits across cog-
nitive domains, we grouped the test variables accord-
ing to neuropsychological conventions (Table 2).
Statistical analysis
Demographic and clinical characteristics were com-
pared between groups, using χ2 and Fisher’s exact
tests for categorical variables or one-way ANOVAs
Table 1. Demographic and clinical characteristics
CG HR UHR HRBip Test statistics
n 50 75 102 30
Gender (F:M) 20:30 32:43 39:63 12:18 χ2=1.19, p=0.52
Pre-morbid verbal IQ 105.94±10.7 103.76±11.0 102.52±12.9 105.16±11.4 F=1.45, p=0.24
Medicationa – 22.89±80 40.42±139 2.12±10 F=1.18, p=0.31
Age (years) 21.06±5.5 22.94±5.2 19.80±4.8 23.71±6.3 F=11.20, p=0.001
PANSS positive – 10.43±3.29 15.26±3.85 8.96±1.89 F=75.08, p<0.001
PANSS negative – 11.69±4.2 16.1±5.6 11.34±4.48 F=18.58, p<0.001
PANSS global – 27.36±6.4 34.56±6.4 26.72±4.8 F=28.35, p<0.001
GAF – 59.21±15.1 51.9±12.1 63.40±11.3 F=11.41, p<0.001
HAMD – 13.39±6.4 16.32±7.8 11.30±6.5 F=7.16, p=0.001
HCL – 18.14±4.5 16.90±5.6 15.61±5.5 F=2.36, p=0.09
MINI screening diagnosesb
Anxiety disordersc – 41 (54.7) 52 (51.0) 18 (60.0) F=0.25, p=0.77
Depressive disorders – 44 (58.7) 69 (67.6) 14 (46.7) F=2.24, p=0.10
Trauma- and stress-related disorders – 1 (1.3) 13 (12.7) 1 (3.3) F=4.56, p=0.01
Eating disorders – 3 (4.0) 3 (2.9) 0 (0.0) F=0.57, p=0.56
SPI-A/CY –
Cognitive–perceptual – 70 (93.3) 77 (75.5) 0
Cognitive disturbances – 46 (61.3) 63 (61.8) 0
SIPS
Attenuated positive symptoms – 0 93 (91.2) 0
Brief limited intermittent psychotic symptoms – 0 7 (6.9) 0
State–trait criteria – 0 15 (14.7) 0
CG, Control group; HR, high risk for psychosis; UHR, ultra-high risk for psychosis; HRBip, high risk for bipolar disorder;
F, female; M, male; PANSS, Positive and Negative Syndrome Scale; GAF, Global Assessment of Functioning; HAMD,
Hamilton Depression Rating Scale; HCL, Hypomania Checklist; MINI, Mini International Neuropsychiatric Interview; SPI-A/
CY, Schizophrenia Proneness Instrument (Adult Version or Child and Youth Version); SIPS, Structured Interview for
Prodromal Syndromes.
a Chlorpromazine equivalents.
b Co-morbid diagnoses were assessed with the diagnostic screening MINI (Sheehan et al. 1998).
c The total number of individuals in each main diagnostic category can be smaller than the sum of the individual diagnoses
because of co-morbidity.
Values given as mean±standard deviation or number (percentage).
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with a Bonferroni post-hoc test for continuous variables.
Using Missing Value Analysis, we ﬁrst identiﬁed sub-
jects with more than three missing values on neuro-
cognitive measures and excluded them from further
analysis. Test scores were standardized by computing
z scores based on the performance of the CG.
Cognitive domain scores were calculated by averaging
the z scores on contributing variables. We then applied
a factor analysis with varimax rotation and an eigen-
value cut-off of ‘1’ to extract ﬁve factors that explained
69% of the total variance (see online Supplementary
Table S1). Those factors represented the independent
cognitive domains of speed, attention, learning and
memory, working memory and ﬂuency. Measures of
the planning/categories domain were excluded from
further analysis because they operationalized higher
and more complex executive functions, with high
cross-loadings on most factors. We then conducted a
repeated-measures ANOVA to compare the cognitive
proﬁles among groups. A univariate ANOVA was per-
formed for individual domain scores. Chlorpromazine
equivalents (Andreasen et al. 2010) and age were
added as covariates in all models. Subsequent logistic
regression models were used to estimate the prob-
ability of group membership with variables that had
proved to be signiﬁcantly different in bivariate ana-
lysis, that is UHR versusHR and schizophrenia conver-
ters versus at-risk psychosis (HR and UHR), based on
their given deﬁcits in functional domains. We then cal-
culated odds ratios (ORs) and 95% conﬁdence intervals
(CIs). Finally, to detect any associations between over-
all severity of positive/negative symptoms and cogni-
tive domains, we determined the partial correlation
coefﬁcients by controlling for age and neuroleptic
medication. To reduce the bias inherent to multiple
testing, we restricted those correlations to cognitive
domains, along with scores for the PANSS and the
GAF and the total score for the MANSA. All analyses
were conducted using SPSS version 20.0 (SPSS Inc.,
USA).
Results
Demographic and clinical characteristics
Based on their demographic and clinical character-
istics, the participants within all groups were found
to be comparable in their verbal/intellectual function-
ing, level of education and gender (Table 1).
However, participants were signiﬁcantly younger in
the UHR group than in the HR and HRBip groups.
Although basic symptoms were common in both
schizophrenic at-risk states of HR and UHR, the
three at-risk groups differed signiﬁcantly in terms of
the severity of their positive, negative and depressiveT
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symptoms and in their level of general functioning. By
contrast, all had equivalent affective symptoms, based
on HCL ratings, and equivalent neuroleptic medi-
cation. By 1 year after completing the initial assess-
ment, 15 of the 177 HR or UHR subjects (8.4%) had
converted to schizophrenic psychosis. In the UHR
group, 13 (12.7%) individuals converted, and in the
HR group, two (2.6%) converted.
Neurocognitive domains
The neuropsychological proﬁles for the three at-risk
groups are displayed in Fig. 1. Table 3 summarizes
the results of the one-way ANOVAs, which contrasted
the performances of individuals in those groups with
healthy CG persons, based on z scores adjusted for
age. Our comparison of cognitive domain factors be-
tween HR/UHR subjects and the CG revealed that sub-
jects at risk for psychosis were impaired in all domains
(all p>0.01), with effect sizes (z scores) ranging from
−0.87 to −1.27 for UHR and from −0.33 to −0.78 for
HR. Scores for HRBip subjects were comparable to
CG members in the domains of attention (F=2.86,
trend p value=0.095) and learning/memory (F=3.21,
trend p value=0.077). The UHR group performed
markedly worse than HR in the domains for speed
(F=9.01, p<0.001), attention (F=5.99, p=0.003), work-
ing memory (F=3.66, p=0.028) and ﬂuency (F=6.20,
p=0.003). The two at-risk groups (HR versus UHR)
scored fairly low in the domains of learning and mem-
ory (F=1.67, p=0.19). When compared with the HRBip
participants, those in the other two at-risk groups were
markedly worse in the domains for speed (F=12.05,
p<0.001), ﬂuency (28.31, p<0.001), attention (F=13.50,
p<0.001) and working memory (F=17.52, p<0.001)
but not for learning and memory (F=0.60, p=0.43).
The direct comparison of HR versus HRBip produced
no signiﬁcant differences in any category (all p<0.10).
To control for depressive symptoms, we conducted a
post-hoc series of ANOVAs, using that factor as an
additional covariate but ﬁnding no signiﬁcant change
in the results (data not shown).
Logistic regression models demonstrated that the
domain of speed was negatively associated with
being classiﬁed as UHR (versus HR: OR 0.48, 95% CI
0.28–0.78) whereas the other domains did not predict
group membership (Table 4). That is, a poor result in
the speed domain was linked to an increased likeli-
hood of being classiﬁed as UHR. A second analysis fo-
cusing on the subgroup of individuals who ultimately
converted to psychosis indicated that it was possible
to identify clearly those converters within the HR
and UHR groups based on their scores in the domain
of learning and memory. Accordingly, learning and
memory were negatively associated with a conversion
to psychosis (OR 0.47, 95% CI 0.25–0.87).
Correlation with psychopathological symptoms
Among the subjects at risk for psychosis, scores along
the PANSS positive symptom scale were negatively
associated with speed (r=−0.21, p<0.001), learning/
memory (r=−0.32, p<0.001) and working memory
(r=−0.21, p=0.003). Scoring along the negative
Fig. 1. Mean scores in cognitive domains for the three at-risk groups [high risk (HR) or ultra-high risk (UHR) for
schizophrenic and affective psychoses and high risk for bipolar disorder (HRBip)], presented as z-score deﬁcits relative to the
healthy control group (CG).
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symptom scale was negatively associated with speed
(r=−0.16, p=0.028), learning/memory (r=−0.26,
p<0.001) and ﬂuency (r=−0.21, p=0.003). GAF scores
were positively associated with the domain of working
memory (r=0.20, p=0.01). Measures of attention
were signiﬁcantly associated with the MANSA total
score (0.24, p=0.037). The HRBip group scores along
the PANSS negative symptom scale were negatively
associated with the learning and memory domain
(F=−0.51, p=0.004). We also conﬁrmed the correlation
between working memory and general functioning
forHRBip (r=0.42, p=0.021) and the association of atten-
tion with the MANSA total score (0.16, p=0.036). No
other associationwasproven signiﬁcant, anddepressive
symptoms in particular were not correlated with any
cognitive domain.
Discussion
We analyzed the neurocognitive performance of
subjects at risk for schizophrenic or affective psy-
choses. Our aim was to determine whether our three
psychopathologically deﬁned risk groups could be dis-
tinguished based on their neuropsychological proﬁles.
Three main ﬁndings emerged. First, for all domains,
the three at-risk groups were impaired relative to the
CG. Here, persons in the HR or HRBip group had com-
parable scores that were intermediate between the CG
Table 3. Test scores and results from one-way ANOVAs of neurocognitive measures
Domain measure
CG HR UHR HRBip Test statistic
Mean S.D. Mean S.D. Mean S.D. Mean S.D. F p value
Speed
TMT_A 21.49 6.1 24.14 6.3 29.76 8.7 26.04 7.66 15.56 <0.001
TMT_B 48.99 12.8 62.85 2.1 63.30 19.0 56.83 14.30 8.53 <0.001
DSCT 83.55 15.0 74.90 15.0 67.48 15.8 75.75 13.40 11.78 <0.001
Attention
CPT_RT 435.06 71.9 461.92 103.0 482.70 103.1 488.83 120.80 2.91 0.032
CPT_Omission 0.38 0.6 1.00 3.0 2.80 5.2 0.27 0.52 6.84 <0.001
Learning/Memory
RAVLT_T1 8.90 2.4 7.68 2.4 7.39 2.1 8.23 2.40 18.40 <0.001
RAVLT_ΣT1–5 62.40 6.4 56.16 10.0 52.98 11.2 58.70 10.40 17.67 <0.001
RAVLT_Recall 13.76 1.7 11.47 3.2 11.06 2.9 12.33 3.50 10.37 <0.001
RAVLT_delrec 14.42 1.7 13.16 3.4 13.27 2.3 13.43 3.20 2.94 0.061
RVDLT_T1 6.12 1.8 5.45 2.2 5.27 2.3 5.90 2.00 1.94 0.120
RVDLT_ ΣT1–5 53.26 8.9 49.73 12.0 47.97 11.8 54.40 8.40 4.09 0.007
RVDLT_Recall 13.12 1.7 12.07 3.15 11.78 3.0 13.27 1.40 4.20 0.006
RVDLT_delrec 14.58 0.8 14.15 1.1 13.65 1.9 14.60 0.62 6.30 0.001
Working memory
DS_total 18.96 3.5 16.88 3.4 15.47 3.3 17.53 4.90 10.34 <0.001
LNS 13.33 2.8 10.57 2.2 10.12 2.8 12.07 3.07 17.29 <0.001
Fluency
RWT_S-Words 16.76 3.1 13.28 3.7 11.44 3.8 12.93 4.5 22.16 <0.001
RWT_Animals 23.04 2.9 21.43 4.4 19.40 5.1 21.67 5.1 7.98 <0.001
Planning/Categories
ToH_mov 55.20 15.7 53.40 17.5 61.53 23.4 63.00 32.3 1.99 0.116
ToH_RT 174.70 68.5 228.30 197.1 267.50 218.0 221.50 146.9 2.31 0.077
WCST_pers 5.49 11.2 6.87 11.8 10.13 11.9 3.23 5.9 3.80 0.011
CG, Control group; HR, high risk for psychosis; UHR, ultra-high risk for psychosis; HRBip, high risk for bipolar disorder;
TMT-A, Trail Making Test, Version A; TMT-B, Trail Making Test, Version B; DSCT, Digit Symbol Coding Test; CPT,
Continuous Performance Test (RT, reaction time; Omission, number of omissions); RAVLT, Rey Auditory Verbal Learning
Test (T1, Trial 1; ΣT1–5, Sum Trials 1–5; delrec, delayed recognition); DS, Digit Span; LNS, Letter-Number Sequencing; RWT,
Verbal Fluency Test (Regensburger Wortﬂüssigkeits-Test); ToH, Tower of Hanoi; WCST, Wisconsin Card Sorting Test; S.D.,
standard deviation.
A one-way ANOVA was performed for each measure, using group (CG, HR, UHR and HRBip) as between-subject factor
and age as covariate.
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and UHR group. Second, among subjects at risk for
psychosis, their performance in the speed domain pre-
dicted a group afﬁliation of UHR whereas learning/
memory deﬁcits predicted a transition to psychosis.
Third, neuropsychological deﬁcits had a profound ef-
fect on an individual’s level of general functioning
and satisfaction with life.
As we had hypothesized, all risk groups differed
from the group of healthy controls in their neuropsy-
chological functioning after controlling for age, gender,
IQ and neuroleptic medication. This indicates that
their impairments were not simply a general intellec-
tual deﬁcit. Our ﬁndings are consistent with those
from previous studies that examined individuals
equivalent to our UHR subjects (Hawkins et al. 2004;
Brewer et al. 2005; Lencz et al. 2006; Eastvold et al.
2007; Pﬂueger et al. 2007) and those involving persons
with basic symptoms (Pukrop et al. 2006; Simon et al.
2007; Frommann et al. 2011). Proﬁles were quantitat-
ively similar between our HRBip and HR subjects.
However, in HRBip, deﬁcits were less pronounced, al-
beit not signiﬁcantly, in the domains of attention and
learning/memory. Similar to the results reported by
Thompson et al. (2003), we found no putative prod-
rome features that clearly distinguished between HR
and HRBip. Therefore, we could not prove our hypo-
thesis that members of the HR psychosis group
would show quantitatively more severe deﬁcits in the
speed domain when compared with those in the
HRBip group.
Regression analysis revealed that, within the groups
at risk for psychosis (HR and UHR), a poor result in
the speed domain was the most reliable predictor of
an afﬁliation to the late UHR state. Other researchers
have also determined that psychomotor speed is
more consistent (Seidman et al. 2010; Kelleher et al.
2013) than reported (non-speed-dependent) deﬁcits
in working memory and executive functioning
(Hawkins et al. 2004; Gschwandtner et al. 2006; Keefe
et al. 2006; Niendam et al. 2006; Pukrop et al. 2006).
The cognitive processes and variables loading on our
factor ‘speed’ were the same as those used in the
MATRICS Consensus Cognitive Battery ‘speed of pro-
cessing’ (Green & Nuechterlein, 2004). These involved
perceptual and motor components, all emphasizing
speed of performance. In accord with results described
by Kelleher et al. (2013), our ﬁndings demonstrate that
processing speed is a central deﬁcit associated with
risk. Moreover, from a multi-level assessment of sub-
jects at risk for psychosis, Riecher-Rössler et al. (2013)
have shown that, in addition to psychotic (suspicious-
ness) and negative symptoms (anhedonia/asociality), a
reduced speed in information processing can heighten
an individual’s overall prediction to transition by up to
80.9%.
The classiﬁcation of HR versus UHR is based on the
assumption that symptom severity increases more or
less linearly as a person progresses through the pro-
dromal phase (Klosterkotter et al. 2011; Fusar-Poli et al.
2013). Whether an individual’s neuropsychological
impairments develop along a similar trajectory is not
clearly understood. Green et al. (2000) have suggested
that those impairments might already be present at a
very early age, manifested by neurodevelopmental ab-
normalities, and might increase with successive stages
of prodromal symptomatology. Likewise, Frommann
et al. (2011) have compared members of HR and UHR
groups and found executive deﬁcits in subjects who
had only basic symptoms in addition to memory deﬁc-
its in subjects who fulﬁlled the UHR criteria. In our
study, a general impairment was observed with rising
degree from HR to UHR. This suggests a parallel and
interconnected development of neuropsychological
deﬁcits and observed psychiatric symptomatology.
Table 4. Results of logistic regression analysis
Domain
Sample statistics
Model
HR UHR Converter
UHR versus HR Converter versus UHR/HR
Mean±S.D. Mean±S.D. Mean±S.D. OR (95% CI) p value OR (95% CI) p value
Speed −0.53±0.8 −1.16±1.0 −1.05±0.8 0.48 (0.28–0.78) 0.004 –
Attention −0.49±1.1 −1.13±1.3 −0.36±0.6 0.83 (0.60–1.16) 0.272 –
Learning/Memory −0.72±1.0 −0.90±0.9 −1.60±1.1 – – 0.47 (0.25–0.87) 0.017
Working memory −0.70±0.7 −0.98±0.9 −1.15±0.9 1.50 (0.78–2.86) 0.21 –
Fluency −0.78±0.9 −1.28±1.0 −1.72±1.0 0.77 (0.47–1.24) 0.283 0.85 (0.42–1.74) 0.663
Age 0.39±0.9 −0.41±0.8 −0.11±0.8 0.42 (0.26–0.67) 0.000 0.69 (0.30–1.58) 0.381
HR, High risk for psychosis; UHR, ultra-high risk for psychosis; S.D., standard deviation; OR odds ratio;
CI, conﬁdence interval.
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Conﬁrming this hypothesis, we note that the measures
of speed and learning/memory were inversely asso-
ciated with both positive and negative symptoms.
Working memory performance was associated with
positive symptoms whereas performance in ﬂuency
tasks was linked with the severity of negative
symptoms. Regression analysis further revealed that,
overall, the actual converters could clearly be dis-
tinguished from all other at-risk subjects because of
diminished performance in their learning and memory
domain. Accordingly, a meta-analysis by DeHerdt et al.
(2013) has shown that performance in learning/memory
can be differentiated between psychosis converters
and non-converters. Hippocampal volume reduction
has also been documented in HR and UHR groups
(Fusar-Poli et al. 2011), and has been connected to
poor recall by UHR subjects (Hurlemann et al. 2008).
Taken together, these ﬁndings are evidence that levels
of cognitive impairment increase through the pro-
dromal stages of psychosis.
Neurocognitive functioning is assumed to inﬂuence
occupational matters and employment status. It is
highly probable that our ﬁnding of a strong association
between neurocognitive performance and a person’s
level of general functioning is an expression of this.
On that account, it has been argued that environmental
factors assessed during the initial screening, such as
being unemployed, should be included in any risk
assessment (Koutsouleris et al. 2011). This would be
particularly useful because the transition of vulner-
ability into prodrome, and ultimately to the point of
psychotic crisis, may be triggered by relevant environ-
mental factors (Falkai et al. 2013).
A meta-analysis by Fusar-Poli et al. (2012a) revealed
a modest effect toward reduced transition risks for the
most recently published studies. It has been reported
that the transition rate declines to 10–18% within
1 year (Yung & Nelson, 2013); our results fell within
this range. This might be because individuals are re-
ferred earlier or their treatment may be more effective.
According to the dilution effect (early detection of psy-
chosis becomes well known, and clinicians are more
likely to ask about psychotic-like symptoms), the num-
ber of individuals truly at risk may be diluted with
‘false positives’ (Yung & Nelson, 2013). Overall, for a
substantial proportion of the subjects initially labeled
as at risk, their conversion to psychosis may never
happen. This is a debated issue, especially because a
potentially unnecessary diagnosis might give rise to
unintended consequences such as stigma and discrimi-
nation (Yung et al. 2010). Nevertheless, individuals
fulﬁlling at-risk criteria already show multiple mental
and functional deﬁcits for which they seek help
(Ruhrmann et al. 2010) and need monitoring indepen-
dent of the outcome (Fusar-Poli et al. 2014). The level
of performance observed in at-risk individuals
(who show no conversion during the follow-up
period) is distinctly lower than in healthy individuals
(Hambrecht et al. 2002; Brewer et al. 2005; Keefe et al.
2006; Niendam et al. 2006; Pukrop et al. 2006).
However, it remains an open question whether the
deﬁcits in these at-risk individuals and the inter-
mediate deﬁcits in ‘truly positive’ individuals lie
along a continuum. That is, the pattern of cognitive
deﬁcits observed in at-risk compared to healthy indivi-
duals at baseline may reﬂect a temporary expression of
psychiatric stress in general rather than a compelling
degradation associated with the path to manifestation
of a disorder. The at-risk psychosis state is further
characterized by a marked impairment in psychosocial
functioning (Velthorst et al. 2010), many co-morbidities
(Yung et al. 2008) and ﬂuctuations in psychiatric
symptoms, such that neuropsychological perfor-
mance may vary. The better performance of the
at-risk group than the converter group may hypo-
thetically be a result of a subset of ‘false positives’
within the sample (Bora & Murray, 2013; Zipursky
et al. 2013).
Limitations to our research include its cross-sectional
nature. Notions of an ‘early’ HR and ‘late’ UHR state
are based on theoretical considerations (Klosterkotter
et al. 2011; Fusar-Poli et al. 2013). More longitudinal
studies are needed to afﬁrm this directly because dif-
ferent pathways to the disorder are possible. Further-
more, little is known about symptom expression in
adolescents (Schimmelmann et al. 2013). Differences
in the predictive power of verbal versus visual learning
have been discussed in the literature (De Herdt et al.
2013). In our study, a comparison of verbal versus
visual learning and memory performance was not per-
formed because the measurements were shown to be
dependent in the factor analysis.
Neuropsychological performances differed among
our three at-risk groups. Therefore, the previously
deﬁned risk classiﬁcation on the basis of psycho-
pathological symptoms alone is now reﬂected also at
the neuropsychological level. Psychomotor deﬁcits,
which are primarily non-speciﬁc, may have subtly
affected the performance of the more complex, higher
cognitive functions. Above all, the social and
vocational outcomes may have been more strongly
inﬂuenced by neurocognitive deﬁcits than by psychi-
atric symptoms. Together with prior evidence, our
ﬁndings imply that subjects at risk for psychosis
already have substantial cognitive deﬁcits. Therefore,
to prevent a downward spiral of neurocognitive
deﬁcits, educational or occupational crises, and loss
of social embedment that may trigger a transition to
psychosis, we suggest that practitioners should recog-
nize cognition as a treatment target in itself.
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